摘要
Background: Hepatocellular carcinoma (HCC) is a malignant tumor with a high mortality rate and poor prognosis in patients. Its pathogenesis is a complex process of multi-factors and multi-steps. However, the etiology and exact molecular mechanism are not completely clear.Methods: Here, we constructed a specific-expressed network based on RNA sequencing data. Gene and miRNA expression profiles and clinical evidence were integrated to detect hepatocellular carcinoma survival modules. Finally, we attempted to identify potential key biomarkers and drug targets by integrating drug sensitivity analysis and immune infiltration analysis.Results: A total of 42 prognostic modules for hepatocellular carcinoma were detected. The prognostic modules were significantly enriched with known cancer-related molecules and 12.93 % molecules of prognostic modules had been found were the targets of small molecule drug. In addition, we found that 38 of 42 (90.48 %) essential genes were associated with the proportions of at least one of the 7 immune cell types.Conclusion: We integrated clinical prognosis information, RNA sequencing data, and drug activity data to explore risk modules of hepatocellular carcinoma. Through drug sensitivity analysis and immune infiltration analysis, we assessed the value of hub genes in the modules as potential biomarkers and drug targets for hepatocellular carcinoma. The protocol provides new insight into parsing the molecular mechanism and theoretical basis of hepatocellular carcinoma.
学科与关键词
- Analysis of multiple databases identifies crucial genes correlated with prognosis of hepatocellular carcinomaLin, Zhifeng; Huang, Xuqiong; Ji, Xiaohui; Tian, Nana; Gan, Yu; Ke, Li*Scientific Reports, 2022, 12(1): 9002.被引 1
- Construction of HBV gene-related prognostic and diagnostic models for hepatocellular carcinomaMa, Keqiang; Wu, Hongsheng*; Ji, Lei*Frontiers in Genetics, 2023, 13: 1065644.
- The Association between Immune Subgroups and Gene Modules for the Clinical, Cellular, and Molecular Characteristic of Hepatocellular CarcinomaChen, Wenbiao; Zhu, Peng; Xu, Huixuan; Hou, Xianliang; Guo, Changchun*Journal of Oncology, 2022, 2022: 7253876.
